Turning Points

Filter By:

Article Type
Year
  • Kizzmekia ‘Kizzy’ Corbett, a viral immunologist and research fellow, is the team lead for coronavirus research within the Viral Pathogenesis Laboratory of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health.

    • Kizzmekia Corbett
    Turning Points
  • Francesco Paolo Russo, an Associate Professor of Gastroenterology at the Department of Surgery, Oncology and Gastroenterology of the University Hospital in Padua, Italy, talks about carrying out research, teaching and clinical work in the midst of the COVID-19 pandemic.

    • Francesco Paolo Russo
    Turning Points
  • Rickie Patani is Professor of Human Stem Cells and Regenerative Neurology at University College London and The Francis Crick Institute, and is a consultant neurologist at The National Hospital for Neurology, Queen Square, London. He has over a decade of experience using human stem cell models of neurodegeneration, and his research contributions have been recognized by the International Paulo Gontijo Award in Medicine and the International 3Rs prize.

    • Rickie Patani
    Turning Points
  • Tolullah ‘Tolu’ Oni is an urban epidemiologist at the Medical Research Council Epidemiology Unit at the University of Cambridge and a Next Einstein Forum Fellow and World Economic Forum Young Global Leader.

    • Tolullah Oni
    Turning Points
  • Muzlifah Haniffa is a dermatologist working at Newcastle University and Wellcome Sanger Institute. Her achievements were recognized by the 2019 Foulkes Foundation Medal awarded by the Academy of Medical Sciences. She also plays a pioneering role in the Human Cell Atlas initiative.

    • Muzlifah Haniffa
    Turning Points
  • Xiling Shen is the Hawkins Family Associate Professor of Biomedical Engineering and director of the Woo Center for Big Data and Precision Health at Duke University. He is a National Science Foundation early-career awardee, chair of the National Cancer Institute’s Patient-Derived Models of Cancer consortium and an Israeli faculty fellow.

    • Xiling Shen
    Turning Points
  • Rachel Ramoni is chief research and development officer for the Department of Veterans Affairs, where she oversees 2,000 active projects at more than 100 sites.

    • Rachel Ramoni
    Turning Points
  • Julie Makani is an associate professor in the Department of Haematology and Blood Transfusion at Muhimbili University of Health and Allied Sciences in Dar es Salaam, where she helped Tanzania establish one of the world’s largest single-center study cohorts for sickle cell disease. She received the 2011 Royal Society Africa Award on the translation of genomics to health benefits.

    • Julie Makani
    Turning Points
  • Sergiu Pașca is a faculty member at Stanford University, where he is also the Uytengsu Director of the Stanford Brain Organogenesis Program. He is a pioneer in developing 3D brain-region-specific organoids, assembloids and cellular models of neuropsychiatric disease from stem cells.

    • Sergiu P. Pașca
    Turning Points
  • Patrícia Brasil is head of the Laboratory of Acute Febrile Illness of the National Institute of Infectious Diseases Evandro Chagas, Fiocruz, and professor of tropical medicine and clinical research in the postgraduate programs of Fiocruz in Rio de Janeiro, Brazil.

    • Patrícia Brasil
    Turning Points
  • Jie Qiao is a reproductive physician and biologist who is President and Chief Physician of Peking University Third Hospital. She is also Director of the National Clinical Research Center on Obstetrics & Gynecology and a member of the Chinese Academy of Engineering. Additionally, Professor Qiao is President of China Women Doctors Association and Chair for the Reproductive Medical Society of Chinese Medical Doctor Association.

    • Jie Qiao
    Turning Points
  • Serena Nik-Zainal is a CRUK Advanced Clinician Scientist and Honorary Consultant in Clinical Genetics. Her clinical work involves rare genetic disorders, and her research focuses on cancer genomics at the University of Cambridge, UK.

    • Serena Nik-Zainal
    Turning Points
  • Eliezer Van Allen is an assistant professor at Harvard Medical School, medical oncologist at Dana-Farber Cancer Institute and associate member of the Broad Institute of MIT and Harvard.

    • Eliezer M. Van Allen
    Turning Points
  • Siddhartha Jaiswal is an assistant professor at Stanford University School of Medicine, where he is also a member of the Immunology Program and the Institute for Stem Cell Biology and Regenerative Medicine.

    • Siddhartha Jaiswal
    Turning Points
  • Kristen Hege is corporate vice president of translational medicine at Celgene and a clinical professor at University of California, San Francisco (UCSF). She serves on the board of the Society for Immunotherapy of Cancer and was recognized by FierceBiotech as one of the top women in biopharma.

    • Kristen Hege
    Turning Points
  • Dena B. Dubal is a physician–scientist and the endowed chair in aging and neurodegenerative disease in the neurology department at the University of California, San Francisco. She has received awards from the National Institutes of Health and American Federation for Aging Research.

    • Dena B. Dubal
    Turning Points